Cargando…

Update on twice-daily bromfenac sodium sesquihydrate to treat postoperative ocular inflammation following cataract extraction

Ophthalmic bromfenac sodium sesquihydrate is a topically applied selective cyclooxygenase (COX)-2 inhibitor. It is similar to amfenac, except for a bromine atom at the C(4) of the benzoyl ring position, which markedly affects its in vitro and in vivo potency, extends the duration of anti-inflammator...

Descripción completa

Detalles Bibliográficos
Autores principales:	Carreño, Ester, Portero, Alejandro, Galarreta, David J, Herreras, José M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2012
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3346189/ https://www.ncbi.nlm.nih.gov/pubmed/22570544 http://dx.doi.org/10.2147/OPTH.S23381

Ejemplares similares

Topical Bromfenac Sodium in Femtosecond Laser-Assisted Cataract Surgery
por: Aguilar Sierra, María Camila, et al.
Publicado: (2020)

Management of ocular inflammation and pain following cataract surgery: focus on bromfenac ophthalmic solution
por: Cho, Hyung, et al.
Publicado: (2009)

Efficacy and safety of sodium bromfenac eye drops in the treatment of postoperative inflammation in cataract surgery: A protocol for systematic review and meta-analysis
por: Wang, Chunyue, et al.
Publicado: (2020)

Bromfenac ophthalmic solution for the treatment of postoperative ocular pain and inflammation: safety, efficacy, and patient adherence
por: Rajpal, Rajesh K, et al.
Publicado: (2014)

Use of topical bromfenac for treating ocular pain and inflammation beyond cataract surgery: a review of published studies
por: Schechter, Barry A
Publicado: (2019)

Twice-Daily vs. Once-Daily Dosing with 0.075% Bromfenac in DuraSite: Outcomes from a 14-Day Phase 2 Study
por: Trattler, William, et al.
Publicado: (2017)

Safety and efficacy of twice daily administration of KPI-121 1% for ocular inflammation and pain following cataract surgery
por: Kim, Terry, et al.
Publicado: (2018)

Chondroitin sulfate-chitosan nanoparticles for ocular delivery of bromfenac sodium: Improved permeation, retention, and penetration
por: Abdullah, Tara Abdulrahman, et al.
Publicado: (2016)

Environmentally Benign and Facile Process for the Synthesis of Pantoprazole Sodium Sesquihydrate: Phase Transformation of Pantoprazole Sodium Heterosolvate to Pantoprazole Sodium Sesquihydrate
por: Awasthi, Arun Kumar, et al.
Publicado: (2017)

Effects of Topical Prostaglandin Analog on Macular Thickness Following Cataract Surgery with Postoperative Topical Bromfenac Treatment
por: Park, Kee Sup, et al.
Publicado: (2020)

Protective effect of bromfenac sodium on femtosecond laser-assisted cataract surgery via modulating cyclooxygenase-2 expression
por: Lu, Lu, et al.
Publicado: (2020)

Sodium N,2-dichlorobenzenesulfonamidate sesquihydrate
por: Gowda, B. Thimme, et al.
Publicado: (2010)

Ocular insert for sustained delivery of gatifloxacin sesquihydrate: Preparation and evaluations
por: Khurana, Gaurav, et al.
Publicado: (2012)

Corneal sensitivity after topical bromfenac sodium eye-drop instillation
por: Yanai, Kaori, et al.
Publicado: (2013)

Norfloxacin sesquihydrate
por: Ravindra, Nittala V., et al.
Publicado: (2009)

Sodium N-bromo-2-chlorobenzenesulfonamidate sesquihydrate
por: Gowda, B. Thimme, et al.
Publicado: (2011)

Sodium N-chloro-2-methylbenzenesulfonamidate sesquihydrate
por: Gowda, B. Thimme, et al.
Publicado: (2009)

A randomized double-masked study to compare the ocular safety, tolerability, and efficacy of bromfenac 0.075% compared with vehicle in cataract surgery subjects
por: Hosseini, Kamran, et al.
Publicado: (2016)

Topical bromfenac for prevention and treatment of cystoid macular edema following cataract surgery: a review
por: Sheppard, John D
Publicado: (2016)

Effect of 0.1% Bromfenac for Preventing Macular Edema after Cataract Surgery in Patients with Diabetes
por: Song, Seok Hyeon, et al.
Publicado: (2020)

The efficacy of bromfenac ophthalmic solution 0.07% dosed once daily in achieving zero-to-trace anterior chamber cell severity following cataract surgery
por: Silverstein, Steven M, et al.
Publicado: (2014)

Surgical outcomes of uveitic glaucoma
por: Carreño, Ester, et al.
Publicado: (2010)

Combination of Aflibercept and Bromfenac Therapy in Age-Related Macular Degeneration: A Pilot Study Aflibercept and Bromfenac in AMD
por: Wyględowska-Promieńska, Dorota, et al.
Publicado: (2015)

Comparison of Once-Daily Bromfenac 0.07% Versus Once-Daily Nepafenac 0.3% in Patients Undergoing Phacoemulsification
por: Toyos, Melissa M.
Publicado: (2019)

Prospects to the formation and control of potential dimer impurity E of pantoprazole sodium sesquihydrate
por: Awasthi, Arun Kumar, et al.
Publicado: (2019)

Solubility measurement and thermodynamic modeling of pantoprazole sodium sesquihydrate in supercritical carbon dioxide
por: Sodeifian, Gholamhossein, et al.
Publicado: (2022)

Efficacy and safety of bromfenac 0.09% and sodium hyaluronate 0.4% combination therapy, versus placebo in patients with pterygium I–III for clinical signs on ocular inflammation
por: Chávez-Mondragón, Eduardo, et al.
Publicado: (2019)

The ocular distribution of (14)C-labeled bromfenac ophthalmic solution 0.07% in a rabbit model
por: Baklayan, George A, et al.
Publicado: (2014)

The Effects of Two Non-Steroidal Anti-Inflammatory Drugs, Bromfenac 0.1% and Ketorolac 0.45%, on Cataract Surgery
por: Jung, Ji Won, et al.
Publicado: (2015)

Bromfenac-induced neurotrophic keratitis in a corneal graft
por: Raj, Nimmy, et al.
Publicado: (2022)

Ocular pharmacokinetics and tolerability of bimatoprost ophthalmic solutions administered once or twice daily in rabbits, and clinical dosing implications
por: Shen, Jie, et al.
Publicado: (2017)

Magnesium Hydroxide Nanoparticles Improve the Ocular Hypotensive Effect of Twice Daily Topical Timolol Maleate in Healthy Dogs
por: Kita, Mizuki, et al.
Publicado: (2021)

In Vivo Pharmacokinetics of Bromfenac Ophthalmic Solution 0.075%, Bromfenac Ophthalmic Solution 0.07%, and Nepafenac/Amfenac Ophthalmic Suspension 0.3% in Rabbits
por: Sheppard, John D., et al.
Publicado: (2018)

Practical guide to choosing dabigatran 150 mg twice daily or apixaban 5 mg twice daily for patients with atrial fibrillation
por: Kobayashi, Zen, et al.
Publicado: (2019)

Benzamidinium tetrahydropentaborate sesquihydrate
por: Portalone, Gustavo
Publicado: (2008)

Sesquicaesium hemisodium tetracyanidoplatinate(II) sesquihydrate
por: Weber, Andrew P., et al.
Publicado: (2010)

On the Mechanism of Formation and the Synthesis of Pantoprazole Sodium Sesquihydrate-Related Compound E: A Phantom Chemical Entity
por: Yari, Ahmad, et al.
Publicado: (2019)

Postoperative Endophthalmitis After Cataract Surgery: An Update
por: Althiabi, Saad, et al.
Publicado: (2022)

Frosted Branch Angiitis Diagnosed as Neuro-Behçet: A Diagnostic and Etiologic Dilemma
por: Portero, Alejandro, et al.
Publicado: (2011)

Ocular pharmacokinetics and tolerability of bimatoprost ophthalmic solutions administered once or twice daily in rabbits, and clinical dosing implications [Corrigendum]
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_5b26baqnqs9dm6vofb11gedli7